Chemistry Wealth Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Hold
1,712
0.03% 206
2026
Q1
$205K Hold
1,712
0.04% 199
2025
Q4
$233K Hold
1,712
0.04% 179
2025
Q3
$253K Hold
1,712
0.05% 175
2025
Q2
$221K Hold
1,712
0.05% 180
2025
Q1
$205K Buy
+1,712
New +$212K 0.05% 180
2024
Q4
Sell
-1,712
Closed -$231K 191
2024
Q3
$231K Hold
1,712
0.05% 158
2024
Q2
$232K Hold
1,712
0.06% 147
2024
Q1
$221K Sell
1,712
-180
-10% -$21.7K 0.06% 150
2023
Q4
$216K Buy
+1,892
New +$189K 0.07% 141
2023
Q3
Sell
-1,892
Closed -$213K 150
2023
Q2
$213K Buy
+1,892
New +$200K 0.07% 138
2023
Q1
Sell
-1,892
Closed -$209K 149
2022
Q4
$209K Buy
+1,892
New +$198K 0.08% 131

Other funds holding XYL

Chemistry Wealth Management's XYL Position: Q2 2026 in Review

Chemistry Wealth Management held its Xylem (XYL) position steady in Q2 2026 at 1,712 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #206.

Chemistry Wealth Management first reported a position in XYL in Q4 2022 and has held it in 12 quarters since. The position peaked at $253K in Q3 2025. 456 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Chemistry Wealth Management held 1,712 shares of Xylem worth $202K as of Q2 2026.
  • Chemistry Wealth Management left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.03% of Chemistry Wealth Management's portfolio in Q2 2026, its #206 holding.
  • Chemistry Wealth Management first reported a position in Xylem in Q4 2022 and has held it in 12 quarters since.
  • Chemistry Wealth Management's Xylem position peaked at $253K in Q3 2025.
  • 456 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.